The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage

British Journal of Neurosurgery

Volumn 25, Issue 1, 2011, Pages 117-119

  Hertle, Daniel N ^a   Hähnel, Stefan ^a   Richter, Götz M ^a   Unterberg, Andreas ^a   Sakowitz, Oliver W ^a   Kiening, Karl L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

case report; essential thrombocytosis; Heparin induced thrombocytopenia; ICH; intracerebral haemorrhage; low molecular weight heparin

Indexed keywords

DANAPAROID; ENOXAPARIN; HYDROXYUREA;

AGED; AMINOTRANSFERASE BLOOD LEVEL; APHASIA; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEADACHE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARIN INDUCED THROMBOCYTOPENIA TYPE II; HUMAN; LIVER DYSFUNCTION; LIVER THROMBOEMBOLISM; MALE; NEUROSURGERY; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; THROMBOCYTE TRANSFUSION; THROMBOCYTOSIS; THROMBOEMBOLISM; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; CEREBRAL HEMORRHAGE; CHONDROITIN SULFATES; CHROMOSOME BREAKAGE; CHROMOSOME DISORDERS; DERMATAN SULFATE; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARITIN SULFATE; HUMANS; MALE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 79951693412     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2010.502266     Document Type: Article

References (9)

1. Mendelow AD, Unterberg A. Surgical treatment of intracerebral haemorrhage. Curr Opin Crit Care 2007;13:169-74. Review.
2. Franchini M. Heparin-induced thrombocytopenia: an update. Thromb J 2005;4:14. Review.
3. González-Duarte A, García-Ramos GS, Valdés-Ferrer SI, Cantú-Brito C. Clinical description of intracranial hemorrhage associated with bleeding disorders. J Stroke Cerebrovasc Dis 2008;17:204-7. (Pubitemid 351853442)
4. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 2006;118:165-76. Review.
5. Martek N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia and low-molecular-wight heparin thromboprophylaxis: a meta-analysis. Blood 2005;106:2710-5. (Pubitemid 41510744)
6. Pohl C, Harbrecht U, Greinacher A, Theuerkauf I, Biniek R, Hanfland P, Klockgether T. Neurologic complications in immunemediated heparin induced throbmocytopenia. Neurology 2000;54:1240-5.
7. Darwish RS, Amiridze NS, James RF, Schreibman D. Management of phlegmasia alba dolens using hirudin in a neurosurgical patient with heparin-induced thrombocytopenia. J Neurosurg Anesthesiol 2004;16:171-3. (Pubitemid 39090042)
8. Hoh BL,Manish A, Johnny CP, Christopher SO. Heparin-induced thrombocytopenia type II in subarachnoid hemorrhage patients: incidence and complications. Neurosurgery 2005;57:243-8.
9. Tsai HC, Yen HC, Hsu JC, Lin CL. Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery. Br J Neurosurg 2009;23:95-6.